Cassava Sciences, Inc. (SAVA)

2.205 0.00 (0.00%) USD  |  NASDAQ  |  Dec 24, 12:20
More

Cassava Sciences SG&A Expense (TTM): 68.06M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
cbdMD, Inc. 14.13M
BioMarin Pharmaceutical, Inc. 973.41M
Amicus Therapeutics, Inc. 353.07M
Geron Corp. 160.96M
NovaBay Pharmaceuticals, Inc. 8.584M